228 related articles for article (PubMed ID: 17822928)
1. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins.
Taylor DR; Hooper NM
Semin Cell Dev Biol; 2007 Oct; 18(5):638-48. PubMed ID: 17822928
[TBL] [Abstract][Full Text] [Related]
2. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.
Parkin ET; Watt NT; Hussain I; Eckman EA; Eckman CB; Manson JC; Baybutt HN; Turner AJ; Hooper NM
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11062-7. PubMed ID: 17573534
[TBL] [Abstract][Full Text] [Related]
3. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
Taylor DR; Whitehouse IJ; Hooper NM
PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
[TBL] [Abstract][Full Text] [Related]
4. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.
Hooper NM
Biochem Soc Trans; 2005 Apr; 33(Pt 2):335-8. PubMed ID: 15787600
[TBL] [Abstract][Full Text] [Related]
5. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
6. Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases.
Fantini J; Garmy N; Mahfoud R; Yahi N
Expert Rev Mol Med; 2002 Dec; 4(27):1-22. PubMed ID: 14987385
[TBL] [Abstract][Full Text] [Related]
7. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
8. The prion protein and lipid rafts.
Taylor DR; Hooper NM
Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
[TBL] [Abstract][Full Text] [Related]
9. The role of lipid rafts in prion protein biology.
Lewis V; Hooper NM
Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
[TBL] [Abstract][Full Text] [Related]
10. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
12. Delineating common molecular mechanisms in Alzheimer's and prion diseases.
Barnham KJ; Cappai R; Beyreuther K; Masters CL; Hill AF
Trends Biochem Sci; 2006 Aug; 31(8):465-72. PubMed ID: 16820299
[TBL] [Abstract][Full Text] [Related]
13. Glypican-1 facilitates prion conversion in lipid rafts.
Hooper NM
J Neurochem; 2011 Mar; 116(5):721-5. PubMed ID: 20681952
[TBL] [Abstract][Full Text] [Related]
14. Membrane rafts in Alzheimer's disease beta-amyloid production.
Vetrivel KS; Thinakaran G
Biochim Biophys Acta; 2010 Aug; 1801(8):860-7. PubMed ID: 20303415
[TBL] [Abstract][Full Text] [Related]
15. Prions, prionoids and pathogenic proteins in Alzheimer disease.
Ashe KH; Aguzzi A
Prion; 2013; 7(1):55-9. PubMed ID: 23208281
[TBL] [Abstract][Full Text] [Related]
16. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
17. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death.
Kudo W; Petersen RB; Lee HG
Prion; 2013; 7(2):114-6. PubMed ID: 23154635
[TBL] [Abstract][Full Text] [Related]
18. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
19. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides.
Forloni G; Tagliavini F; Bugiani O; Salmona M
Prog Neurobiol; 1996 Jul; 49(4):287-315. PubMed ID: 8888112
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
Bate C; Williams A
J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
